Cargando…

Antiretroviral Drug Activity in Macaques Infected during Pre-Exposure Prophylaxis Has a Transient Effect on Cell-Associated SHIV DNA Reservoirs

BACKGROUND: Pre-exposure prophylaxis (PrEP) with emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) is a novel HIV prevention strategy. Suboptimal PrEP adherence and HIV infection creates an opportunity for continued antiretroviral drug activity during undiagnosed infection. We previously sho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cong, Mian-er, Pau, Chou-Pong, Heneine, Walid, García-Lerma, J. Gerardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091888/ https://www.ncbi.nlm.nih.gov/pubmed/27806064 http://dx.doi.org/10.1371/journal.pone.0164821

Ejemplares similares

Limited SHIV env diversification in macaques failing oral antiretroviral pre-exposure prophylaxis
por: Zheng, Qi, et al.
Publicado: (2012)

Efficacy of topical tenofovir against transmission of a tenofovir-resistant SHIV in macaques
por: Dobard, Charles W, et al.
Publicado: (2015)

Prevention of Vaginal SHIV Transmission in Macaques by a Coitally-Dependent Truvada Regimen
por: Radzio, Jessica, et al.
Publicado: (2012)

Drug resistance emergence in macaques administered cabotegravir long-acting for pre-exposure prophylaxis during acute SHIV infection
por: Radzio-Basu, Jessica, et al.
Publicado: (2019)

Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and Tenofovir
por: García-Lerma, J. Gerardo, et al.
Publicado: (2008)

T Cell Chemo-Vaccination Effects after Repeated Mucosal SHIV Exposures and Oral Pre-Exposure Prophylaxis
por: Kersh, Ellen N., et al.
Publicado: (2011)

Single oral dose for HIV pre or post-exposure prophylaxis: user desirability and biological efficacy in macaques
por: Massud, Ivana, et al.
Publicado: (2020)

Persistence of Viral Reservoirs in Multiple Tissues after Antiretroviral Therapy Suppression in a Macaque RT-SHIV Model
por: Kline, Christopher, et al.
Publicado: (2013)

Single dose topical inserts containing tenofovir alafenamide fumarate and elvitegravir provide pre- and post-exposure protection against vaginal SHIV infection in macaques
por: Dobard, Charles W., et al.
Publicado: (2022)

Development of a repeat-exposure penile SHIV infection model in macaques to evaluate biomedical preventions against HIV
por: Garber, David A., et al.
Publicado: (2018)

Ultra-long-acting in-situ forming implants with cabotegravir protect female macaques against rectal SHIV infection
por: Young, Isabella C., et al.
Publicado: (2023)

A mAb for the detection of the antiretroviral drug emtricitabine
por: Youngpairoj, Ae S., et al.
Publicado: (2022)

A recombinant measles virus vaccine strongly reduces SHIV viremia and virus reservoir establishment in macaques
por: Nzounza, Patrycja, et al.
Publicado: (2021)

Using geospatial modeling to optimize the rollout of antiretroviral-based pre-exposure HIV interventions in Sub-Saharan Africa
por: Gerberry, David J., et al.
Publicado: (2014)

Two-dose emtricitabine/tenofovir alafenamide plus bictegravir prophylaxis protects macaques against SHIV infection
por: Bekerman, Elena, et al.
Publicado: (2020)

Long-acting lenacapavir acts as an effective preexposure prophylaxis in a rectal SHIV challenge macaque model
por: Bekerman, Elena, et al.
Publicado: (2023)

Analysis of Multiply Spliced Transcripts in Lymphoid Tissue Reservoirs of Rhesus Macaques Infected with RT-SHIV during HAART
por: Deere, Jesse D., et al.
Publicado: (2014)

Persistence of Virus Reservoirs in ART-Treated SHIV-Infected Rhesus Macaques after Autologous Hematopoietic Stem Cell Transplant
por: Mavigner, Maud, et al.
Publicado: (2014)

An Antiretroviral/Zinc Combination Gel Provides 24 Hours of Complete Protection against Vaginal SHIV Infection in Macaques
por: Kenney, Jessica, et al.
Publicado: (2011)

Transmitted/founder SHIV.D replicates in the brain, causes neuropathogenesis, and persists on combination antiretroviral therapy in rhesus macaques
por: Podgorski, Rachel M., et al.
Publicado: (2023)

Antimicrobial prophylaxis does not improve post-surgical outcomes in SIV/SHIV-uninfected or SIV/SHIV-infected macaques (Macaca mulatta and Macaca fascicularis) based on a retrospective analysis
por: Moats, Cassandra, et al.
Publicado: (2022)

Biphasic decay of intact SHIV genomes following initiation of antiretroviral therapy complicates analysis of interventions targeting the reservoir
por: Kumar, Mithra R., et al.
Publicado: (2023)

Brief Report: HIV-1 Evolution in Breakthrough Infections in a Human Trial of Oral Pre-exposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate
por: Ruone, Susan, et al.
Publicado: (2016)

Epigenetic drug Gar1041 in combination with antiretroviral therapy transiently reduces the proviral DNA reservoir in SIVmac251-infected macaques
por: Lewis, MG, et al.
Publicado: (2010)

The Recombinant Maize Ribosome-Inactivating Protein Transiently Reduces Viral Load in SHIV89.6 Infected Chinese Rhesus Macaques
por: Wang, Rui-Rui, et al.
Publicado: (2015)

Antibody mediated protection of immunized macaques against pathogenic SHIV challenge
por: Srivastava, Indresh K, et al.
Publicado: (2006)

Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus
por: Lagenaur, Laurel A, et al.
Publicado: (2011)

Epigallocatechin-3-gallate local pre-exposure application prevents SHIV rectal infection of macaques
por: Liu, JB, et al.
Publicado: (2018)

Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaques
por: Walker-Sperling, Victoria E. K., et al.
Publicado: (2022)

Prophylactic and therapeutic effect of AZT/3TC in RT-SHIV infected Chinese-origin rhesus macaques
por: Wang, Wei, et al.
Publicado: (2014)

Altered gene expression in asymptomatic SHIV-infected rhesus macaques (Macacca mulatta)
por: Carroll, Erica E, et al.
Publicado: (2006)

RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy
por: Shao, Wei, et al.
Publicado: (2009)

Gammaherpesvirus infection and malignant disease in rhesus macaques experimentally infected with SIV or SHIV
por: Marshall, Vickie A., et al.
Publicado: (2018)

CTL-mediated immunotherapy can suppress SHIV rebound in ART-free macaques
por: Fan, Jin, et al.
Publicado: (2019)

Long-acting capsid inhibitor protects macaques from repeat SHIV challenges
por: Vidal, Samuel J., et al.
Publicado: (2021)

TLR7 agonist, N6-LS and PGT121 delayed viral rebound in SHIV-infected macaques after antiretroviral therapy interruption
por: Hsu, Denise C., et al.
Publicado: (2021)

Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection
por: Van Rompay, Koen KA, et al.
Publicado: (2007)

Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose
por: Sholukh, Anton M, et al.
Publicado: (2014)

Well-mixed plasma and tissue viral populations in RT-SHIV-infected macaques implies a lack of viral replication in the tissues during antiretroviral therapy
por: Kearney, Mary F., et al.
Publicado: (2015)

Longitudinal analysis of the lung microbiota of cynomolgous macaques during long-term SHIV infection
por: Morris, Alison, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_288rlk4uuobfo946lbrthr7end